- This applies to conventional intermittent 3 times a week hemodialysis
- Per KDOQI 2006 guidelines: For patients with minimal residual renal function (<2ml/min per 1.73m2)
- Minimally adequate dose should be a spKt/V of 1.2
- Target recommended dose should be a spKt/V of 1.4 (or eKT/V of 1.2)
- Per KDOQI 2006 guidelines: For patients with minimal residual renal function (<2ml/min per 1.73m2)
- There is a lack of randomized studies to support the minimum dialysis dose of spKt/V ≥1.2.
- However, retrospective studies suggest that a Kt/V <1.0 is associated with poor outcomes and that a Kt/V ≥1.2 is associated with better survival123.
- The HEMO study4 showed that targeting a spKt/V higher than 1.4 did not improve survival or reduce hospitalization rates over 2.8 years.
CLINICAL PEARLS:
|
Sources:
- Owen WF Jr, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001.
- Gotch FA, Levin NW, Port FK et al. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis. 1997;30(1):1.
- Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50(2):550.
- Eknoyan G, Beck, GJ Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010. Hemodialysis study (HEMO)